3D Printing Technology in Pharmaceutical Manufacturing
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biofabrication and Biomanufacturing".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 119
Special Issue Editors
Interests: product and process development; industrial and physical pharmacy; additive manufacturing; controlled and targeted drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: formulations design and development; novel and controlled delivery systems; manufacturing sciences; biopharmaceutics; 3D printing
Special Issue Information
Dear Colleagues,
This Special Issue examines the fundamental principles and techniques of 3D printing technology in pharmaceutical manufacturing. It explores the application of 3D printing in drug development which allows for precise fabrication of personalized dosage forms and specialized and complex drug delivery systems, thereby highlighting the potential of 3D printing to enhance drug solubility, bioavailability, and controlled release profiles.
This Special Issue further discusses the integration of pharmaceutical sciences, engineering, and medical disciplines in utilizing 3D printing for personalized medicine, including patient-specific formulations based on scanning and imaging technologies. It also addresses the regulatory considerations and challenges associated with incorporating 3D printing technology in pharmaceutical manufacturing, such as quality control, validation, and standardization.
Overall, this Special Issue aims to provide insights into the transformative potential of 3D printing technology in pharmaceutical manufacturing. The research within this Special Issue contributes to the development of innovative drug delivery systems, personalized medicines and dosage forms, paving the way for improved therapeutic efficacy and patient outcomes.
Dr. Ziyaur Rahman
Dr. Mansoor A. Khan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical manufacturing
- 3D printing technology
- drug development
- personalized medicine
- dosage forms
- drug release
- patient-specific formulations
- additive manufacturing
- drug delivery systems
- regulatory considerations
